why choose us

First received: April 29, 2024

Clinical Trial: Propionic Acid in Multiple Sclerosis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Multiple Sclerosis

Study Type: INTERVENTIONAL


Official Title: Propionic Acid in Multiple Sclerosis - a Placebo-controlled Randomized Double-blinded Clinical Trial

Brief Summary: The purpose of this study is to demonstrate the superiority of propionic acid over placebo as add on treatment in multiple sclerosis (MS).

Read more